Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,092.00
Bid: 1,095.00
Ask: 1,096.00
Change: 1.00 (0.09%)
Spread: 1.00 (0.091%)
Open: 1,101.00
High: 1,102.00
Low: 1,090.00
Prev. Close: 1,091.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Supreme Ct Hearing Denial, Petersen Interests Sale

24 Jun 2019 14:37

RNS Number : 2309D
Burford Capital Limited
24 June 2019
 

This announcement contains inside information.

 

24 June 2019

 

US SUPREME COURT DENIES PETERSEN HEARING, FURTHER BURFORD SALE OF PETERSEN INTERESTS

 

Sale of 10% of Petersen entitlement yields $100 million at an implied $1 billion valuation

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and investment management firm focused on law, announces that the US Supreme Court has declined to hear Argentina's and YPF's appeals in the Petersen case, with the result that the lower court decisions finding jurisdiction for Petersen's claims in the US are now final. The Petersen case will now return to the trial court for merits proceedings. This continues an unbroken string of victories for the Petersen case in the courts. While we are pleased with this decision, it is important to emphasise that this decision relates purely to a preliminary jurisdictional question and does not foreshadow any particular result in the underlying litigation.

 

Although the Supreme Court's decision is a matter of public record, Burford has issued this announcement as a matter of convenience. However, Burford does not intend to regularly issue such releases for other interlocutory steps in the proceedings, of which there are likely to be many before a final resolution.

 

Burford also announces that it has sold a further 10% of its entitlement in the Petersen matter into the secondary market it has been developing, leaving Burford with 61.25% of its original entitlement. The sale price was $100 million, implying a value of $1 billion for Burford's entire original Petersen entitlement. Burford has now generated $236 million in proceeds from Petersen sales. As the market value of the Petersen matter has continued to rise (and as Burford also has further exposure to YPF-related claims through the Company's investment in the parallel Eton Park matter), reducing Burford's total holding and locking in significant profits represents prudent portfolio management. However, Burford has committed always to hold at least 50.1% of its original economic entitlement in the Petersen matter. The sale was to 11 institutional investors and was significantly over-subscribed. Including prior purchasers, there are now approximately 40 institutional investors participating in the Petersen secondary market.

 

Burford will consider the impact of the Supreme Court's decision and further secondary market trading activity as part of its investment valuation process for the six months ended 30 June 2019. Our valuation process is discussed in detail in our annual reports.

 

The person responsible for arranging for the release of this announcement on behalf of the Company is Elizabeth O'Connell, Chief Financial Officer.

 

 

For further information, please contact:

 

Burford Capital Limited

Elizabeth O'Connell, CFA, Chief Financial Officer

+1 212 235 6825

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

Nicholas Harland

Liberum Capital Limited - Joint Broker

+44 (0)20 3100 2222

Richard Crawley

Jamie Richards

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

Jonathan Abbott

Montfort Communications Limited - Financial Communications

+44 (0)20 3770 7908

Robert Bailhache - email

 

 

About Burford Capital

Burford Capital is the leading global finance and investment management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

 

This release does not constitute an offer of any Burford fund.  Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STREADKLADDNEFF
Date   Source Headline
26th May 202212:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSExtension of SWF Arrangement & Fund Management
25th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
24th May 20223:30 pmRNSDirector/PDMR Shareholding
24th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
23rd May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
20th May 20225:38 pmRNSResult of AGM
20th May 20224:17 pmRNSPricing of Early Redemption of Bonds Due 2022
20th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
19th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
18th May 20228:00 amRNSNotice of Retail Shareholder Call on June 16, 2022
18th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
17th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
16th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
13th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
10th May 20228:00 amRNSNotice of Early Redemption of Bonds Due 2022
19th Apr 20227:00 amRNSAccess to Summary Judgment Filings in YPF Cases
13th Apr 20225:39 pmRNSCompleted Share Purchase by Employee Benefit Trust
13th Apr 202212:00 pmRNSNotice of 2022 AGM
12th Apr 20227:00 amRNSClosing of Private Offering of Senior Notes
11th Apr 20227:00 amRNSChristopher A. Halmy Nominated as Board Director
8th Apr 202211:30 amRNSDirector/PDMR Shareholding
7th Apr 20227:05 amRNSPricing and Upsizing of Senior Notes Offering
6th Apr 202211:30 amRNSDirector/PDMR Shareholding
4th Apr 20221:15 pmRNSPrivate Offering of Senior Notes
4th Apr 20227:00 amRNSManagement Team Invest $3 Million in Burford Stock
1st Apr 20225:59 pmRNSIntended Purchases of Ordinary Shares
29th Mar 202212:43 pmRNSAvailability of Annual Report
29th Mar 202212:13 pmRNSFull Year Results 2021
28th Mar 20227:00 amRNS$360m Pre-Settlement Investment Fund Close
15th Mar 202212:00 pmRNSNotice of FY21 Earnings Call Details
4th Mar 202212:00 pmRNSNotice of FY21 Results & Earnings Call
1st Mar 20224:53 pmRNSBurford Capital - $100m Equity Project Commitments
15th Feb 20227:00 amRNSUpdate on 2021 Business Activity & Accounting
8th Feb 20223:10 pmRNSBurford Capital's Affirmative Recovery Research
19th Jan 20224:30 pmRNSTR1 - Notification of Major Holdings
24th Dec 202110:00 amRNSTR1 - Notification of Major Holdings
23rd Dec 20217:00 amRNSStatement concerning non-cash accrual
15th Nov 20213:00 pmRNSSterling FX Rate for 2021 Interim Dividend
3rd Nov 20212:00 pmRNSDirector/PDMR Shareholding
2nd Nov 202111:57 amRNSMaterials for Investor Event
12th Oct 20212:00 pmRNSNotice of Investor Event Registration Details
27th Sep 202111:00 amRNSDirector/PDMR Shareholding
27th Sep 20218:30 amRNSCompleted Share Purchase by Employee Benefit Trust
20th Sep 20218:30 amRNSDirector/PDMR Shareholding
17th Sep 20218:30 amRNSDirector/PDMR Shareholding
16th Sep 20218:30 amRNSIntended Share Purchase by Employee Benefit Trust
16th Sep 20217:00 amRNSCompleted Share Purchase for NED Share Plan
15th Sep 202111:00 amRNSDirector/PDMR Shareholding
15th Sep 20218:30 amRNSIntended Share Purchase for NED Share Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.